XML 163 R42.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Equity (Deficit) (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2026 | Dec. 31, 2025
Equity [Abstract] |  |
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model | There were no options granted during the three months ended March 31, 2026. The assumptions used to determine the fair value of options granted in the three months ended March 31, 2025 using the Black-Scholes-Merton model are as follows: Schedule of Fair Value of Options Granted Black-Scholes-Merton Model
Dividend yield |  |  | - | %
Risk-free interest rate |  |  | 3.62 to 4.23 | %
Expected volatility (weighted-average and range, if applicable) |  |  | 100 | %
Expected term |  |  | 6 to 6.5 years |
| The assumptions used to determine the fair value of options granted in the year ended December 31, 2025 using the Black-Scholes-Merton option model are as follows: Schedule of Fair Value of Options Granted Black-Scholes-Merton Model
Dividend yield |  |  | - |
Risk-free interest rate |  |  | 3.5% to 4.4 | %
Expected volatility |  |  | 93.4% to 115.5 | %
Expected term in years |  |  | 5 to 6.5 |
The assumptions used to determine the fair value of options granted in the year ended December 31, 2024 using the Black-Scholes-Merton model are as follows:
Dividend yield |  |  | 0 | %
Risk-free interest rate |  |  | 3.6% to 4.2 | %
Expected volatility |  |  | 100 | %
Expected term in years |  |  | 6 to 6.5 |
Schedule of Stock Option Activities and Related Information | A summary of the Company’s stock option activities and related information for the three-month ended March 31, 2026 is as follows: Schedule of Stock Option Activities and Related Information
Stock Option |  | No. of Stock Option |  |  | Weighted-Average Exercise Price |  |  | Weighted-Average Remaining Contractual Life (in Years) |
January 1, 2026 |  |  | 538,618 |  |  | $ | 11.25 |  |  |  | 9.3 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | - |  |  |  | - |  |  |  | - |
March 31, 2026 |  |  | 538,618 |  |  | $ | 11.25 |  |  |  | 9.0 |
Vested and expected to vest, March 31, 2026 |  |  | 538,618 |  |  | $ | 11.25 |  |  |  | 9.0 |
A summary of the Company’s stock option activities and related information for the three months ended March 31, 2025 is as follows:
Stock Option |  | No. of Stock Option |  |  | Weighted-Average Exercise Price |  |  | Weighted-Average Remaining Contractual Life (in Years) |
January 1, 2025 |  |  | 105,090 |  |  | $ | 98.55 |  |  |  | 0.7 |
Granted |  |  | 127,153 |  |  |  | 3.40 |  |  |  | 1.3 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | (20,731 | ) |  |  | (69.07 | ) |  |  | - |
March 31, 2025 |  |  | 211,512 |  |  | $ | 44.24 |  |  |  | 1.0 |
| A summary of the Company’s stock option activities and related information for the year ended December 31, 2025 is as follows: Schedule of Stock Option Activities and Related Information
Stock Option |  | No. of Stock Option |  |  | Weighted-Average Grant Date Exercise Price |  |  | Weighted-Average Remaining Contractual Life (In Years) |
Balance, January 1, 2025 |  |  | 105,090 |  |  | $ | 98.55 |  |  |  | 0.65 |
Granted |  |  | 540,827 |  |  |  | 3.89 |  |  |  | 9.5 |
Forfeited |  |  | (107,299 | ) |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Balance, December 31, 2025 |  |  | 538,618 |  |  | $ | 11.25 |  |  |  | 9.3 |
Vested and expected to vest December 31, 2025 |  |  | 538,618 |  |  | $ | 11.25 |  |  |  | 9.3 |
Stock Option |  | No. of Stock Option |  |  | Weighted-Average Grant Date Exercise Price |  |  | Weighted- Average Remaining Contractual Life (In Years) |
January 1, 2024 |  |  | 114,301 |  |  | $ | 108.62 |  |  |  | 1.65 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | (9,211 | ) |  |  | (76.60 | ) |  |  | - |
December 31, 2024 |  |  | 105,090 |  |  | $ | 98.55 |  |  |  | 0.65 |
Schedule of Options Outstanding | The following options were outstanding at their respective exercise price on March 31, 2026 and December 31, 2025, respectively: Schedule of Options Outstanding
Exercise Price Options Outstanding |  | March 31, 2026 |  |  | December 31, 2025 |
$1.27 |  |  | 25,000 |  |  |  | 25,000 |
$2.22 |  |  | 23,781 |  |  |  | 23,781 |
$2.40 |  |  | 364,893 |  |  |  | 364,893 |
$6.40 |  |  | 7,326 |  |  |  | 7,326 |
$7.80 |  |  | 5,731 |  |  |  | 5,731 |
$8.00 |  |  | 32,700 |  |  |  | 32,700 |
$9.68 |  |  | 34,884 |  |  |  | 34,884 |
$31.20 |  |  | 9,978 |  |  |  | 9,978 |
$62.54 |  |  | 6,825 |  |  |  | 6,825 |
$133.40 |  |  | 27,500 |  |  |  | 27,500 |
Total |  |  | 538,618 |  |  |  | 538,618 |
| The following options were outstanding as of December 31, 2025, at their respective exercise price: Schedule of Options Outstanding
Exercise Price Options Outstanding |  | December 31, 2025 |
$1.27 |  |  | 25,000 |
$2.22 |  |  | 23,781 |
$2.40 |  |  | 364,893 |
$6.40 |  |  | 7,326 |
$7.80 |  |  | 5,731 |
$8.00 |  |  | 32,700 |
$9.68 |  |  | 34,884 |
$31.20 |  |  | 9,978 |
$62.54 |  |  | 6,825 |
$133.40 |  |  | 27,500 |
Total |  |  | 538,618 |
Schedule of Stock Compensation Expenses | Stock compensation expenses are comprised of the following: Schedule of Stock Compensation Expenses
|  | 2026 |  |  | 2025 |
|  | For The Three Months Ended |
|  | 2026 |  |  | 2025 |
Compensation and employee benefits |  | $ | 58,908 |  |  | $ | 152,266 |
Professional services |  |  | - |  |  |  | 588,993 |
Total |  | $ | 58,908 |  |  | $ | 741,259 |
| Stock compensation expenses is comprised of the following: Schedule of Stock Compensation Expenses
|  | 2025 |  |  | 2024 |
|  | Year Ended December 31 |
|  | 2025 |  |  | 2024 |
Compensation and employee benefits |  | $ | 796,565 |  |  | $ | 1,575,952 |
Professional services |  |  | 688,993 |  |  |  | - |
Total |  | $ | 1,485,558 |  |  | $ | 1,575,952 |
Schedule of Restricted Stock Units | The Company did not have any outstanding restricted stock units (“RSUs”) as of March 31, 2026. A summary of the Company’s RSU activity and related information for the three months ended March 31, 2025 is presented below: Schedule of Restricted Stock Units
Restricted Stock Units |  | No. of RSU |  |  | Weighted-Average Grant Date Fair Value Per RSU |  |  | Weighted-Average Remaining Contractual Life (in Years) |
January 1, 2025 |  |  | 8,583 |  |  | $ | 26.20 |  |  |  | 1.00 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Vested |  |  | (4,292 | ) |  |  | 26.20 |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  |  |
Cancelled / Forfeited |  |  | (980 | ) |  |  | - |  |  |  | - |
March 31, 2025 |  |  | 3,311 |  |  | $ | 26.20 |  |  |  | 0.8 |
| A summary of the Company’s RSU activities and related information for the year ended December 31, 2025 and December 31, 2024 is as follows: Schedule of Restricted Stock Units
Restricted Stock Units |  | No. of RSU |  |  | Weighted- Average Grant Date Fair Value Per RSU |  |  | Weighted- Average Remaining Contractual Life (in Years) |
January 1, 2025 |  |  | 8,583 |  |  | $ | 26.20 |  |  |  | 1.00 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Vested |  |  | (5,740 | ) |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | (2,843 | ) |  |  | - |  |  |  | - |
December 31, 2025 |  |  | - |  |  |  | - |  |  |  | - |
Restricted Stock Units |  | No. of RSU |  |  | Weighted- Average Grant Date Fair Value Per RSU |  |  | Weighted- Average Remaining Contractual Life (in Years) |
January 1, 2024 |  |  | 16,175 |  |  | $ | 26.20 |  |  |  | 2.00 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Vested |  |  | (5,392 | ) |  |  | 26.20 |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Cancelled / Forfeited |  |  | (2,200 | ) |  |  | 26.20 |  |  |  | - |
December 31, 2024 |  |  | 8,583 |  |  |  | 26.20 |  |  |  | 1.00 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration